Home > Publications database > Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE). > print |
001 | 156842 | ||
005 | 20240229123118.0 | ||
024 | 7 | _ | |a 10.1158/1078-0432.CCR-20-0103 |2 doi |
024 | 7 | _ | |a pmid:32554541 |2 pmid |
024 | 7 | _ | |a 1078-0432 |2 ISSN |
024 | 7 | _ | |a 1557-3265 |2 ISSN |
024 | 7 | _ | |a altmetric:84192504 |2 altmetric |
037 | _ | _ | |a DKFZ-2020-01159 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Talhouk, Aline |0 0000-0001-7760-410X |b 0 |
245 | _ | _ | |a Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE). |
260 | _ | _ | |a Philadelphia, Pa. [u.a.] |c 2020 |b AACR |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1606134138_2611 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a 2020 Oct 15;26(20):5411-5423 |
520 | _ | _ | |a Gene-expression-based molecular subtypes of high-grade serous tubo-ovarian cancer (HGSOC), demonstrated across multiple studies, may provide improved stratification for molecularly targeted trials. However, evaluation of clinical utility has been hindered by non-standardized methods which are not applicable in a clinical setting. We sought to generate a clinical-grade minimal gene-set assay for classification of individual tumor specimens into HGSOC subtypes and confirm previously reported subtype-associated features.Adopting two independent approaches, we derived and internally validated algorithms for subtype prediction using published gene-expression data from 1650 tumors. We applied resulting models to NanoString data on 3829 HGSOCs from the Ovarian Tumor Tissue Analysis Consortium. We further developed, confirmed, and validated a reduced, minimal gene-set predictor, with methods suitable for a single patient setting.Gene-expression data was used to derive the Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE) assay. We established a de facto standard as a consensus of two parallel approaches. PrOTYPE subtypes are significantly associated with age, stage, residual disease, tumor infiltrating lymphocytes, and outcome. The locked-down clinical-grade PrOTYPE test includes a model with 55 genes that predicted gene-expression subtype with >95% accuracy that was maintained in all analytical and biological validations.We validated the PrOTYPE assay following the Institute of Medicine guidelines for the development of omics-based tests. This fully defined and locked-down clinical-grade assay will enable trial design with molecular subtype stratification and allow for objective assessment of the predictive value of HGSOC molecular subtypes in precision medicine applications. |
536 | _ | _ | |a 313 - Cancer risk factors and prevention (POF3-313) |0 G:(DE-HGF)POF3-313 |c POF3-313 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a George, Joshy |0 0000-0001-8510-8229 |b 1 |
700 | 1 | _ | |a Wang, Chen |0 0000-0003-2638-3081 |b 2 |
700 | 1 | _ | |a Budden, Timothy |b 3 |
700 | 1 | _ | |a Tan, Tuan Zea |0 0000-0001-6624-1593 |b 4 |
700 | 1 | _ | |a Chiu, Derek S |b 5 |
700 | 1 | _ | |a Kommoss, Stefan |b 6 |
700 | 1 | _ | |a Leong, Huei San |b 7 |
700 | 1 | _ | |a Chen, Stephanie |b 8 |
700 | 1 | _ | |a Intermaggio, Maria P |b 9 |
700 | 1 | _ | |a Gilks, Blake |b 10 |
700 | 1 | _ | |a Nazeran, Tayyebeh Mehrane |b 11 |
700 | 1 | _ | |a Volchek, Mila |b 12 |
700 | 1 | _ | |a Elatre, Wafaa |b 13 |
700 | 1 | _ | |a Bentley, Rex C |b 14 |
700 | 1 | _ | |a Senz, Janine |b 15 |
700 | 1 | _ | |a Lum, Amy |b 16 |
700 | 1 | _ | |a Chow, Veronica |b 17 |
700 | 1 | _ | |a Sudderuddin, Hanwei |b 18 |
700 | 1 | _ | |a Mackenzie, Robertson |b 19 |
700 | 1 | _ | |a Leung, Samuel |b 20 |
700 | 1 | _ | |a Liu, Geyi |b 21 |
700 | 1 | _ | |a Johnson, Dustin |b 22 |
700 | 1 | _ | |a Chen, Billy |b 23 |
700 | 1 | _ | |a Ovarian Cancer Study, Australian |b 24 |
700 | 1 | _ | |a Alsop, Jennifer |b 25 |
700 | 1 | _ | |a Banerjee, Susana |b 26 |
700 | 1 | _ | |a Behrens, Sabine |0 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea |b 27 |u dkfz |
700 | 1 | _ | |a Bodelon, Clara |0 0000-0002-6578-2678 |b 28 |
700 | 1 | _ | |a Brand, Alison H |b 29 |
700 | 1 | _ | |a Brinton, Louise A |0 0000-0003-3853-8562 |b 30 |
700 | 1 | _ | |a Carney, Michael E |b 31 |
700 | 1 | _ | |a Chiew, Yoke-Eng |b 32 |
700 | 1 | _ | |a Cushing-Haugen, Kara L |b 33 |
700 | 1 | _ | |a Cybulski, Cezary |b 34 |
700 | 1 | _ | |a Ennis, Darren |b 35 |
700 | 1 | _ | |a Fereday, Sian |b 36 |
700 | 1 | _ | |a Turzanski-Fortner, Renée |0 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2 |b 37 |u dkfz |
700 | 1 | _ | |a García-Donás, Jesus |0 0000-0001-7731-3601 |b 38 |
700 | 1 | _ | |a Gentry-Maharaj, Aleksandra |0 0000-0001-7270-9762 |b 39 |
700 | 1 | _ | |a Glasspool, Rosalind |0 0000-0002-5000-1680 |b 40 |
700 | 1 | _ | |a Goranova, Teodora |b 41 |
700 | 1 | _ | |a Greene, Casey S |0 0000-0001-8713-9213 |b 42 |
700 | 1 | _ | |a Haluska, Paul |b 43 |
700 | 1 | _ | |a Harris, Holly R |0 0000-0002-2572-6727 |b 44 |
700 | 1 | _ | |a Hendley, Joy |b 45 |
700 | 1 | _ | |a Hernandez, Brenda Y |b 46 |
700 | 1 | _ | |a Herpel, Esther |b 47 |
700 | 1 | _ | |a Jimenez-Linan, Mercedes |b 48 |
700 | 1 | _ | |a Karpinskyj, Chloe |b 49 |
700 | 1 | _ | |a Kaufmann, Scott Harold |0 0000-0002-4900-7145 |b 50 |
700 | 1 | _ | |a Keeney, Gary |b 51 |
700 | 1 | _ | |a Kennedy, Catherine J |0 0000-0002-4465-5784 |b 52 |
700 | 1 | _ | |a Köbel, Martin |0 0000-0002-6615-2037 |b 53 |
700 | 1 | _ | |a Koziak, Jennifer |0 0000-0001-5830-0397 |b 54 |
700 | 1 | _ | |a Larson, Melissa C |b 55 |
700 | 1 | _ | |a Lester, Jenny |b 56 |
700 | 1 | _ | |a Lewsley, Liz-Anne |b 57 |
700 | 1 | _ | |a Lissowska, Jolanta |0 0000-0003-2695-5799 |b 58 |
700 | 1 | _ | |a Lubiński, Jan |b 59 |
700 | 1 | _ | |a Luk, Hugh |b 60 |
700 | 1 | _ | |a Macintyre, Geoff |b 61 |
700 | 1 | _ | |a Mahner, Sven |b 62 |
700 | 1 | _ | |a McNeish, Iain A |0 0000-0002-9387-7586 |b 63 |
700 | 1 | _ | |a Menkiszak, Janusz |0 0000-0001-8279-7196 |b 64 |
700 | 1 | _ | |a Nevins, Nikilyn |b 65 |
700 | 1 | _ | |a Osorio, Ana |b 66 |
700 | 1 | _ | |a Oszurek, Oleg |b 67 |
700 | 1 | _ | |a Palacios, Jose |b 68 |
700 | 1 | _ | |a Hinsley, Samantha |0 0000-0001-6903-4688 |b 69 |
700 | 1 | _ | |a Pearce, Celeste L |b 70 |
700 | 1 | _ | |a Pike, Malcolm C |0 0000-0003-4891-1199 |b 71 |
700 | 1 | _ | |a Piskorz, Anna |b 72 |
700 | 1 | _ | |a Ray-Coquard, Isabelle |b 73 |
700 | 1 | _ | |a Rhenius, Valerie |b 74 |
700 | 1 | _ | |a Rodríguez-Antona, Cristina |0 0000-0001-8750-7338 |b 75 |
700 | 1 | _ | |a Sharma, Raghwa |b 76 |
700 | 1 | _ | |a Sherman, Mark E |b 77 |
700 | 1 | _ | |a Silva, Dilrini |b 78 |
700 | 1 | _ | |a Singh, Naveena |b 79 |
700 | 1 | _ | |a Sinn, Hans-Peter |0 0000-0003-2836-6699 |b 80 |
700 | 1 | _ | |a Slamon, Dennis J |b 81 |
700 | 1 | _ | |a Song, Honglin |b 82 |
700 | 1 | _ | |a Steed, Helen |b 83 |
700 | 1 | _ | |a Stronach, Euan A |b 84 |
700 | 1 | _ | |a Thompson, Pamela J |b 85 |
700 | 1 | _ | |a Tołoczko-Grabarek, Aleksandra |b 86 |
700 | 1 | _ | |a Trabert, Britton |0 0000-0002-1539-6090 |b 87 |
700 | 1 | _ | |a Traficante, Nadia |b 88 |
700 | 1 | _ | |a Tseng, Chiu-Chen |b 89 |
700 | 1 | _ | |a Widschwendter, Martin |0 0000-0002-7778-8380 |b 90 |
700 | 1 | _ | |a Wilkens, Lynne R |b 91 |
700 | 1 | _ | |a Winham, Stacey J |0 0000-0002-8492-9102 |b 92 |
700 | 1 | _ | |a Winterhoff, Boris J |b 93 |
700 | 1 | _ | |a Beeghly-Fadiel, Alicia |b 94 |
700 | 1 | _ | |a Benitez, Javier |b 95 |
700 | 1 | _ | |a Berchuck, Andrew |b 96 |
700 | 1 | _ | |a Brenton, James D |0 0000-0002-5738-6683 |b 97 |
700 | 1 | _ | |a Brown, Robert |0 0000-0001-7960-5755 |b 98 |
700 | 1 | _ | |a Chang-Claude, Jenny |0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253 |b 99 |u dkfz |
700 | 1 | _ | |a Chenevix-Trench, Georgia |b 100 |
700 | 1 | _ | |a DeFazio, Anna |0 0000-0003-0057-4744 |b 101 |
700 | 1 | _ | |a Fasching, Peter A |0 0000-0003-4885-8471 |b 102 |
700 | 1 | _ | |a Garcia, Maria J |b 103 |
700 | 1 | _ | |a Gayther, Simon A |b 104 |
700 | 1 | _ | |a Goodman, Marc T |b 105 |
700 | 1 | _ | |a Gronwald, Jacek |b 106 |
700 | 1 | _ | |a Henderson, Michelle J |b 107 |
700 | 1 | _ | |a Karlan, Beth Y |b 108 |
700 | 1 | _ | |a Kelemen, Linda E |0 0000-0003-4362-9784 |b 109 |
700 | 1 | _ | |a Menon, Usha |0 0000-0003-3708-1732 |b 110 |
700 | 1 | _ | |a Orsulic, Sandra |b 111 |
700 | 1 | _ | |a Pharoah, Paul D P |0 0000-0001-8494-732X |b 112 |
700 | 1 | _ | |a Wentzensen, Nicolas |b 113 |
700 | 1 | _ | |a Wu, Anna H |b 114 |
700 | 1 | _ | |a Shildkraut, Joellen |b 115 |
700 | 1 | _ | |a Rossing, Mary Anne |b 116 |
700 | 1 | _ | |a Konecny, Gottfried E |b 117 |
700 | 1 | _ | |a Huntsman, David G |b 118 |
700 | 1 | _ | |a Huang, Ruby Yun-Ju |b 119 |
700 | 1 | _ | |a Goode, Ellen L |b 120 |
700 | 1 | _ | |a Ramus, Susan J |0 0000-0003-0005-7798 |b 121 |
700 | 1 | _ | |a Doherty, Jennifer A |0 0000-0002-1454-8187 |b 122 |
700 | 1 | _ | |a Bowtell, David D L |b 123 |
700 | 1 | _ | |a Anglesio, Michael S |0 0000-0003-1639-5003 |b 124 |
773 | _ | _ | |a 10.1158/1078-0432.CCR-20-0103 |g p. clincanres.0103.2020 - |0 PERI:(DE-600)2036787-9 |n 20 |p 5411-5423 |t Clinical cancer research |v 26 |y 2020 |x 1557-3265 |
909 | C | O | |o oai:inrepo02.dkfz.de:156842 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 27 |6 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 37 |6 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 99 |6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253 |
913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |2 G:(DE-HGF)POF3-300 |v Cancer risk factors and prevention |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
914 | 1 | _ | |y 2020 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-01-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2020-01-06 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |d 2020-01-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-01-06 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |d 2020-01-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-01-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2020-01-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2020-01-06 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CLIN CANCER RES : 2018 |d 2020-01-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-01-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-01-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |d 2020-01-06 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CLIN CANCER RES : 2018 |d 2020-01-06 |
920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C020-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|